However, while turning a bit more optimistic about the company, analysts covering this counter prefer to see whether the company can pull off this multi-pronged execution before they turn fully bullish on it.
Q&M Dental Group (SGX:QC7
) , making no bones about its growth ambitions, has managed to attract some market interest. With its war chest recently replenished by a bond issue, the company has launched concurrent acquisitions of other dental groups in Thailand, Singapore, Australia and China via its separately listed subsidiary, Aoxin Q&M Dental Group.
Q&M, led by founder and CEO Ng Chin Siau, has managed to secure institutional backing for his ventures, too. Notably, Lion Global Investors (LGI) had spent $9 million to buy 20 million shares at 45 cents each. More recently, LGI also took a stake in Aoxin (SGX:1D4) , paying $5.4 million to acquire 30 million shares from Q&M at 18 cents each. Following this deal, Q&M’s stake in Aoxin has been trimmed to 52.93%. Year to date, Q&M and Aoxin shares have gained 9.1% and 19.4% respectively, extending a gain of 114.3% and 377.8% since the start of 2025.
